Compare BHVN & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BHVN | SPRY |
|---|---|---|
| Founded | 2013 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.0B |
| IPO Year | 2022 | 2020 |
| Metric | BHVN | SPRY |
|---|---|---|
| Price | $10.61 | $9.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 2 |
| Target Price | $27.69 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 1.9M | 887.0K |
| Earning Date | 06-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 26.08 | ★ 114.04 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $89,149,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $119.97 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 297063.34 |
| 52 Week Low | $7.48 | $6.66 |
| 52 Week High | $31.80 | $18.63 |
| Indicator | BHVN | SPRY |
|---|---|---|
| Relative Strength Index (RSI) | 40.76 | 42.41 |
| Support Level | $8.40 | $8.61 |
| Resistance Level | $11.92 | $10.44 |
| Average True Range (ATR) | 0.64 | 0.48 |
| MACD | -0.10 | 0.01 |
| Stochastic Oscillator | 23.95 | 46.60 |
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.